Process Development Best Practices for Topical Drug Products.
| Published in: | Pharmaceutical Technology Europe Vol. 31; no. 2; pp. 32 - 36 |
|---|---|
| Main Authors: | , , |
| Format: | Journal Article |
| Published: |
MJH Life Sciences
Feb2019
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=134790386&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 134790386 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 17537967 5NG jtl: Pharmaceutical Technology Europe issn: 17537967 maglogo: N pubinfo: dt: Feb2019 vid: 31 iid: 2 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 134790386 134790386 ppf: 32 ppct: 4 formats: fmt: @attributes: type: P tig: atl: Process Development Best Practices for Topical Drug Products. aug: au: Harrison, Christopher Pratt, Sarah Brown, Marc affil: chief scientific officer and co-founder, all at MedPharm sug: pubtype: Trade Publication doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|